Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

Overview of attention for article published in Archives of Gynecology and Obstetrics, August 2010

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 policy document that references this research output.

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.